Prashant Kesharwani

Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances

Atherosclerosis is an advancing and complex vascular condition primarily associated with sustained inflammatory responses, oxidative imbalance, and disruptions in lipid homeostasis. These pathological features render it a major contributor to the global burden of cardiovascular disease, encompassing both morbidity and...

Gold Nano Biosensing Technologies for Early Breast Cancer Diagnosis: Recent Progress and Future Perspectives

Breast cancer remains one of the foremost causes of cancer‐related mortality among women worldwide, where survival outcomes are strongly dictated by the timeliness and precision of diagnosis. In this review, we present gold nanomaterial‐driven biosensors as a transformative frontier in ultrasensitive breast cancer dete...

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation

Stimuli-Responsive Mesoporous Silica Nanoparticles for Precision Cancer Therapy: Design Principles, Cellular Uptake, and Translational Perspectives.

Premature drug release in the systemic circulation or at off-target sites remains a major challenge in conventional drug delivery systems, often resulting in reduced therapeutic efficacy and increased systemic toxicity. Nanotechnology-based delivery platforms have emerged as promising strategies to address these limita...

Biomimetic Nanoparticles for Metastatic Breast Cancer: Advancing Targeted Drug Delivery Beyond Conventional Nanomedicine.

Breast cancer remains a leading cause of cancer morbidity and mortality worldwide. Although nanomedicines are a promising and rapidly evolving therapeutic platform, their clinical translation remains limited. Depending on the stage and subtype of the disease, systemic treatments and localized strategies are still essen...